| Property | Value |
|---|
|
?:abstract
|
-
As the number of discharged patients with novel coronavirus pneumonia (COVID-19) increased, TCM treatment received more attention Some COVID-19 diagnosis and treatment plans issued by national health commission and local government recorded the syndrome differentiation and classification of TCM in the convalescent period and the treatment prescriptions The clinical characteristics and TCM classification of convalescent period were also reported in recent literatures Deficiency of Qi and Yin is the main syndrome in recovery period, and the Shengmai Powder (SMS) is the representative prescription This paper reviews the studies of SMS in the treatment of deficiency of Qi and Yin, pulmonary fibrosis and vascular endothelial cell injury The feasibility of SMS for the discharged patients with COVID-19 was discussed This review will provide reference for clinical doctors and patients in the recovery period of TCM treatment
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Feasibility of Shengmai powder in convalescent patients with novel coronavirus pneumonia
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}